![James New](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James New
Directeur Général chez
Wavodyne Therapeutics, Inc.
Profil
James New is the founder of Wavodyne Therapeutics, Inc. Former positions include Chief Executive Officer at Abrika Pharmaceuticals LLP from 2002 to 2007, President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2008 to 2009, Chief Executive Officer at AIKO Biotechnology, Inc., President & Chief Executive Officer at Synaptogenix, Inc. in 2014, Director at Neurotrope, Inc. in 2014, Principal at Bristol Myers Squibb Co. from 1980 to 1992, Principal at Pfizer Inc. from 1994 to 1999, Principal at Novartis AG from 1999 to 2001, and Principal at GSK Plc.
Education includes an undergraduate degree from State University of New York College at Geneseo, a doctorate from State University of New York at Buffalo, a graduate degree from the University of Maine, and an MBA from Columbia Business School.
Postes actifs de James New
| Sociétés | Poste | Début |
|---|---|---|
Wavodyne Therapeutics, Inc.
 Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuroinflammatory processes | Directeur Général | - |
Anciens postes connus de James New
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROTROPE, INC. | Directeur Général | 16/07/2014 |
| SYNAPTOGENIX, INC. | Directeur Général | 16/07/2014 |
| VELOXIS PHARMACEUTICALS A/S | Directeur Général | 01/01/2009 |
Abrika Pharmaceuticals LLP
 Abrika Pharmaceuticals LLP Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Directeur Général | 01/01/2007 |
| NOVARTIS AG | Corporate Officer/Principal | - |
Formation de James New
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Abrika Pharmaceuticals LLP
Abrika Pharmaceuticals LLP Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
AIKO Biotechnology, Inc.
 AIKO Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical research solutions and services | Commercial Services |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
State University of New York College at Geneseo
 State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synaptogenix, Inc.
 Synaptogenix, Inc. Packaged SoftwareTechnology Services Develops decentralized blockchain network that focuses on convergence between cryptocurrency and artificial intelligence | Technology Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wavodyne Therapeutics, Inc.
Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuroinflammatory processes | Health Technology |
